Skeletal dysplasia
Showing 1 - 25 of 2,686
Decoding the Genetic Landscape of Skeletal Diseases
Recruiting
- Genetic Skeletal Diseases
- +3 more
-
Stockholm, SwedenKarolinska University Hospital
May 16, 2023
Decision Recommendation of Adult Skeletal Class III Patients
Recruiting
- Skeletal Dysplasia
- Reverse Overjet
-
Cairo, EgyptCairo University
Aug 19, 2023
Extreme Morphology and Metabolic Health
Recruiting
- Skeletal Dysplasia
-
Bath, United KingdomUniversity of Bath
Aug 7, 2023
Fibrous Dysplasia Trial run by the National Institute of Dental and Craniofacial Research (NIDCR) (denosumab)
Recruiting
- Fibrous Dysplasia
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Oct 15, 2022
Data Collection of Patients With Rare Bone Diseases
Recruiting
- Skeletal Dysplasia
-
Bologna, Emilia Romagna, ItalyIrccs Istituto Ortopedico Rizzoli
Feb 21, 2022
Physical Activity, Motor Competence, Pulmonary Function, and
Enrolling by invitation
- Scoliosis; Idiopathic, Infantile
- +8 more
-
Oslo, NorwayOslo University Hospital, Rikshospitalet
Sep 17, 2021
Bone-related Genetic Variants in Families
Terminated
- Skeletal Dysplasia
- Samples With DNA
-
Doha, QatarHamad Medical Corporation
Jul 29, 2020
Non-invasive Functional Assessment and Pathogenesis of Morquio A
Recruiting
- Mucopolysaccharidosis IV Type A
- +2 more
- Imaging, gait analysis, growth, joint test, hearing test, questionnaire, etc.
-
Wilmington, DelawareNemours Children's Health, Delaware Valley
Mar 9, 2022
Mortality of US Fibrodysplasia Ossificans Progressiva (FOP)
Active, not recruiting
- Fibrodysplasia Ossificans Progressiva (FOP)
- Non-Interventional
-
Tarrytown, New YorkRegeneron
Sep 26, 2023
X-linked Hypophosphatemia Trial in New Haven (Burosumab Injection [Crysvita])
Completed
- X-linked Hypophosphatemia
- Burosumab Injection [Crysvita]
-
New Haven, ConnecticutYale University School of Medicine
Oct 7, 2022
Evaluation and Treatment of Skeletal Diseases
Recruiting
- Tumor Induced Osteomalcia
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 25, 2023
Bone Manifestation of Nutritional Disorders Among Infants and
Not yet recruiting
- Bone Loss
- Nutrition Disorders
- (no location specified)
Nov 13, 2023
Fibrous Dysplasia, McCune Albright Syndrome Trial in Leiden (Denosumab 120 Mg/1.7 Ml Inj, Placebo)
Recruiting
- Fibrous Dysplasia
- McCune Albright Syndrome
- Denosumab 120 Mg/1.7 Ml Inj
- Placebo
-
Leiden, NetherlandsLeiden University Medical Center
Jul 20, 2023
SEDC, Hypochondrogenesis, Semd, Strudwick Type Trial in Paris, Madrid (Natural History Study)
Recruiting
- SEDC
- +3 more
- Natural History Study
-
Paris, France
- +1 more
Sep 15, 2022
Fibrous Dysplasia Of Bone Trial run by the National Institute of Dental and Craniofacial Research (NIDCR) (Burosumab)
Not yet recruiting
- Fibrous Dysplasia Of Bone
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Aug 24, 2022
RCDP - Rhizomelic Chondrodysplasia Punctata, RCDP1, RCDP2 Trial in Wilmington
Recruiting
- RCDP - Rhizomelic Chondrodysplasia Punctata
- +5 more
-
Wilmington, DelawareNemours
Sep 26, 2022
Genetic Analysis of the Chiari I Malformation
Completed
- Syringomyelia
- Type I Arnold Chiari Malformation
-
Bethesda, Maryland
- +1 more
Jan 25, 2023
Genesis Electrical Impedance Tomography: A Preliminary Study
Recruiting
- Premature Infant
- +4 more
-
Aurora, ColoradoChildren's Hospital Colorado
Jan 26, 2022
MOPDII, MOPDI, MOPDIII Trial in Wilmington
Recruiting
- MOPDII
- +5 more
-
Wilmington, DelawareNemours
Sep 26, 2022
Craniometaphyseal Dysplasia (CMD)
Recruiting
- Craniometaphyseal Dysplasia
-
Farmington, ConnecticutUniversity of Connecticut Health Center
Jan 24, 2022
Fibrous Dysplasia/McCune-Albright Syndrome Trial in Boston (MRI-based Neuroimaging, Non-contrast MRI, 18F-FDG-PET/CT)
Enrolling by invitation
- Fibrous Dysplasia/McCune-Albright Syndrome
- MRI-based Neuroimaging
- +3 more
-
Boston, MassachusettsBoston Children's Hospital
Sep 1, 2021
Final Height in Patients With CH Diagnosed by the Screening
Not yet recruiting
- Congenital Hypothyroidism
-
Cairo, Abbasiya, EgyptAin Shams University
Oct 1, 2021
Femoroacetabular Impingement, Hip Dysplasia Trial (EOS)
Not yet recruiting
- Femoroacetabular Impingement
- Hip Dysplasia
- EOS
- (no location specified)
Jun 19, 2023
Achondroplasia Trial in Worldwide (Recifercept)
Active, not recruiting
- Achondroplasia
- Recifercept
-
Irvine, California
- +13 more
Jan 20, 2023